Markets › Stocks › OXYGENTAPH

OX

OXYGENTA PHARMACEUTICAL LIMITED

NSE: OXYGENTAPHBSE: 524636Healthcare

Download Research Report7-page PDF

₹50.19

▲ +0.88%

NSE · auto-updates while market open

Mkt Cap

₹190 Cr

P / E

-

P / B

-

ROE

-

52W High

₹133.50

52W Low

₹45.30

Key Metrics

Market Cap

₹190 Cr

P / E

-

P / B

-

EV / EBITDA

-

ROCE

-33.6%

ROE

-

Debt / Equity

-

Book Value

₹-11.54

EPS

-

Div Yield

0.0%

Face Value

-

Promoter Holding

56.5%

Revenue · ₹ Cr

61

FY22

31

FY23

40

FY24

109

FY25

113

FY26

Net Profit · ₹ Cr

-1

-12

-3

-10

-18

FY22FY23FY24FY25FY26

EPS · ₹ per share

₹-0.5

₹-6.4

₹-1.1

FY22FY23FY24

Q1 2026 snapshot

Sales

₹50 Cr

Operating profit

-

OPM

-

Net profit

₹-2 Cr

EPS

-

Scorecard · 7 axes

Quality

Bad

0/100

Valuation

-

Growth

Avg

+8.4%

Profitability

Bad

-16.8%

Performance

Bad

-54.3%

Entry Point

Strong

38%

Red Flags

Strong

0 flags

Shareholding Pattern

Promoter56.5%

DII0.0%

Public43.4%

Quarterly Results · ₹ Cr

Quarter	FY24 12Q	FY25 03Q	FY25 06Q	FY25 09Q	FY25 12Q	FY26 03Q
Revenue	33.69	49.52	15.3	14.25	33.93	49.79
Net Profit	-3.928	-2.153	-6.106	-4.93	-4.843	-1.704
NPM %	-11.7%	-4.3%	-39.9%	-34.6%	-14.3%	-3.4%

Alert Pre-trade